Dates that matter

Web forms for federal surprise-billing disputes move to the IDR Gateway; forms outside the Gateway end Jan. 15, 2027, except the resubmission form.

Both Palmetto and Noridian found the software not reasonable and necessary.

Docket FDA-2026-N-9505; the draft excludes remote telesurgery and autonomous surgical robots and asks for risk assessment of AI features.

Autonomous-radiology and FDA AI sessions.

Webinar for the second part of the agency's prize competition of up to $7.95 million for AI in evidence review and health care data.

The Senate health committee chairman's draft would create a Medicare payment pathway for AI tools and clarify FDA and ONC oversight; comments go to [email protected], Becker's reported.

Regulation (EU) 2026/1744, the AI Omnibus, has been in force since July 27, 2026. Stand-alone high-risk systems follow on December 2, 2027, and AI built into regulated medical devices on August 2, 2028.

Hybrid meeting at the FDA's White Oak campus, 10 a.m. to 4 p.m. Eastern time both days; in-person registration closes Nov. 23.

Mentioned in the long read as one of the few credentials worth the money.

The proposal would let qualified staff review digital images and data away from the testing laboratory under its certificate, except in cytology, and allow digital-image cytology proficiency testing.

Presenter registration closes Nov. 2 and written comments are due Dec. 14.

The Medicare Payment Advisory Commission posts its agenda about a week before each meeting.

Expect a fifth extension or a special-registration final rule in the fourth quarter.

Also on this date: the CMS prior-authorization API requirements and Georgia's SB 444, which bars coverage decisions based solely on AI.

Set by the comptroller's September 16 policy; CT Mirror reports the January 1, 2027 effective date. The comptroller plans to ask the 2027 legislature to extend it to all state-regulated plans.

Signed Sept. 30, 2026; both apply to physician offices and group practices. AB 2575 and SB 903 were vetoed.

Codes X682T, X628T and X629T, and X672T, accepted at the September 2026 panel meeting.

Docket FDA-2026-N-13135; the paper is neither draft nor final guidance.

Federal court in the Northern District of California; the FTC's opposition is due Nov. 25.

Open enrollment began Nov. 1, 2026, with average benchmark premiums up 13%, according to KFF.

Summary of panel actions due Feb. 19, 2027.

The challenge carries a $5.35 million grand prize for AI that speeds evaluation of medical evidence.

Under the final 2027 fee schedule rule, approved Shared Savings Program ACOs may reduce or eliminate Part B cost-sharing for many items and services.

Under Regulation (EU) 2026/1744. AI embedded in regulated medical devices follows on August 2, 2028.

The 2028 cliff for non-behavioral telehealth.